• For Individuals
  • For Institutions
  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
LB Café
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov14
BTIG Maintains Buy Rating on Ovid, Oppenheimer Cuts to Buy
11:21
Nov13
Ovid Therap released FY2025 Q3 earnings on November 12 (EST), actual revenue USD 132 K (forecast USD 170.38 K), actual EPS USD -0.1709 (forecast USD -0.15)
04:00
Ovid Therap released FY2025 9 Months Earnings on November 12, 2025 (EST) with actual revenue of USD 6.534 M and EPS of USD -0.3772
04:00
Oct27
Ovid Therapeutics Inc. to Hold Special Meeting for Voting on Amending the Restated Certificate of Incorporation Proposal
21:30
Oct9
Analyst Olson Covers Ovid Therapeutics
07:56
Oct3
Minter Analysts Show Good Performance in Recommended Healthcare Stocks
16:46

Schedules & Filings

Schedules
Filings
Nov12
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 132 K, Net Income -12.16 M, EPS -0.1709

Aug13
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 6.272 M, Net Income -4.603 M, EPS -0.0647

May13
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 130 K, Net Income -10.06 M, EPS -0.1415

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
TGL
25.660
+279.70%
+18.902
SMX
290.860
+106.28%
+166.220
WHLR
5.680
+75.31%
+2.440
PAVS
0.0450
+42.86%
+0.013
IRBT
4.215
+39.11%
+1.185
PRAX
248.915
+31.03%
+58.945
ALMS
10.855
+30.78%
+2.570
DBRG
12.655
+30.20%
+2.945
TORO
5.290
+28.09%
+1.160
RIME
1.880
+27.88%
+0.381
View More